The current CLNN market cap is 43.04M. The company's latest EPS is USD -0.3855 and P/E is -0.88.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 174k | 234k | 107k | 269k | 108k |
Operating Income | -9.81M | -11.67M | -10.73M | -10.34M | -9.54M |
Net Income | -10.98M | -1.05M | -11.77M | -25.14M | -2.42M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 206k | 723k | 473k | 654k |
Operating Income | -16.33M | -20.21M | -49.98M | -48.41M | -40.54M |
Net Income | -16.16M | -19.28M | -9.74M | -29.92M | -49.5M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 36M | 44.49M | 39.89M | 67.85M | 60.43M |
Total Liabilities | 45.32M | 41.26M | 41.52M | 46.31M | 39.03M |
Total Equity | -9.32M | 3.24M | -1.63M | 21.53M | 21.41M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 14.88M | 68.24M | 63.06M | 44.49M | 52.34M |
Total Liabilities | 9.99M | 67.9M | 50.47M | 41.26M | 38.95M |
Total Equity | -67.77M | 341k | 12.6M | 3.24M | 13.39M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -31.3M | -39.01M | -9.22M | -16.24M | -23M |
Investing | -12.45M | -10.16M | 4.72M | 4.76M | 4.71M |
Financing | 875k | 17.25M | 4.59M | 42.42M | 42.18M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -13.2M | -18.93M | -34.62M | -39.01M | -30.17M |
Investing | -294k | -387k | -1.33M | -10.16M | -1.5M |
Financing | 5.5M | 69.53M | 27.11M | 17.25M | 42.16M |
Market Cap | 43.04M |
Price to Earnings Ratio | -0.88 |
Price to Sales Ratio | 66.67 |
Price to Cash Ratio | 1.52 |
Price to Book Ratio | 3.26 |
Dividend Yield | - |
Shares Outstanding | 128.43M |
Average Volume (1 week) | 4.37M |
Average Volume (1 Month) | 1.46M |
52 Week Change | -66.15% |
52 Week High | 1.09 |
52 Week Low | 0.25 |
Spread (Intraday) | 0.02 (7.09%) |
Company Name | Clene Inc |
Address |
3500 s dupont hwy dover, delaware 19901 |
Website | https://www.clene.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.